• Section 32 Names Steven J. Kafka, Ph.D., as Managing Partner

    8 days ago - By San Diego Biotechnology

    SAN DIEGO--Section 32, a venture capital fund investing at the frontiers of technology, healthcare and life sciences, announced today the appointment of Steven J. Kafka, Ph.D., as a managing partner. Steve will focus on supporting and......
    Read more ...